Meeting Banner
Abstract #1072

In-vivo Imaging of hyperpolarized and purified Fumarate at 11.7 T

Tobias Speidel1, Stephan Knecht2, Martin Gierse2, Tobias Lobmeyer1, Gordon Winter3, Jessica Löffler3, Maximilian Fellermann4, Ilai Schwartz2, Holger Barth4, and Volker Rasche1
1Internal Medicine II, Ulm University Medical Center, Ulm, Germany, 2NVision Imaging Technologies GmbH, Ulm, Germany, 3Department of Nuclear Medicine, Ulm University Medical Center, Ulm, Germany, 4Institute for Pharmacology and Toxicology, Ulm University Medical Center, Ulm, Germany

Synopsis

Hyperpolarized [1-13C] fumarate has been shown to be a reliable imaging biomarker for monitoring cellular necrosis with conversion of [1-13C]fumarate to [1-13C]malate via Fumarate hydratase. However, the inherently low 13C-sensitivity limits biomedical applications with a need for accessible and low-cost hyperpolarization methods.

In this abstract we show that parahydrogen-induced polarization methods can overcome these limitations by providing highly polarized and purified [1-13C]fumarate as a non-toxic perfusion agent with the capabilities of acting as a biomarker of cell necrosis in metabolic 13C MRI.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.

Keywords